Sharps Technology, Inc. (STSS)
NASDAQ: STSS · Real-Time Price · USD
1.775
-0.015 (-0.84%)
Mar 9, 2026, 1:53 PM EDT - Market open
Company Description
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry.
Its product lines focus on providing waste capabilities that incorporate syringe technologies. The company, through a digital asset treasury strategy, focuses on accumulating Solana (SOL), the native digital asset of the Solana blockchain.
The company was incorporated in 2017 and is based in Melville, New York.
Sharps Technology, Inc.
| Country | United States |
| Founded | 2017 |
| IPO Date | Apr 14, 2022 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 55 |
| CEO | Paul Danner |
Contact Details
Address: 105 Maxess Road, Suite 124 Melville, New York 11747 United States | |
| Phone | 631 574 4436 |
| Website | sharpstechnology.com |
Stock Details
| Ticker Symbol | STSS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.25 |
| CIK Code | 0001737995 |
| CUSIP Number | 82003F309 |
| ISIN Number | US82003F3091 |
| Employer ID | 82-3751728 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Paul Kruger Danner III | Executive Chairman and Principal Executive and Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 23, 2026 | 8-K | Current Report |
| Feb 13, 2026 | SCHEDULE 13D/A | Filing |
| Feb 13, 2026 | SCHEDULE 13D | Filing |
| Jan 30, 2026 | EFFECT | Notice of Effectiveness |
| Jan 26, 2026 | SCHEDULE 13G | Filing |
| Jan 23, 2026 | SCHEDULE 13G/A | Filing |
| Jan 16, 2026 | 8-K | Current Report |
| Jan 16, 2026 | 8-K | Current Report |
| Jan 15, 2026 | SCHEDULE 13G/A | Filing |
| Jan 15, 2026 | SCHEDULE 13G/A | Filing |